Value of MR in Differential Diagnosis of Prostate Carcinoma

TONG Yan-jun,WANG Xiao-ying,LI Fei-yu,JIANG Xue-xiang

DOI: https://doi.org/10.3321/j.issn:1003-3289.2006.07.027

2006-01-01

Abstract:Objective To assess the value of MR in differential diagnosis of the prostate cancer. Methods The clinical data and prostate MR imaging of 374 patients in past twelve years were analyzed retrospectively. Their referred purpose of MR examination was to differentiate the lesion in the prostate gland. With the dividing line of August 2002, they were divided into two groups (early period group and late period group) according to the different MR scanner and scan technique. Their clinical data and efficiency of MR in the differential diagnosis were compared. Results ① Clinical situation: there were 139 patients in the early period group and 235 in the late period group. Their ages and the proportion of patients with symptoms of benign prostate hyperplasia (BPH),suspect of metastasis or others was not statistically significant(P0.05). The average level of serum prostate specific antigen (PSA) ( ng/ml of early period group vs ng/ml of late period group) was not statistically significant (P0.05), whereas the proportion of patients with elevated PSA and abnormal prostate evaluation on digital rectal examination or on ultrasound dropped, and the difference between the two groups was statistically significant (P0.05). ② The efficiency of differential diagnosis of MR: the qualification of sensitivity, specificity, accuracy, positive and negative predicating value were 64.0%, 82.0%, 70.5%, 86.4% and 56.2% in the early period group and were 69.6%, 88.0%, 80%, 81.6% and 79.1% in the late period group, respectively. The difference of accuracy and negative predicating value between the two groups was statistically significant (P0.05), whereas the difference of sensitivity, specificity and positive predicating value was not statistically significant (P0.05). Conclusion With the application of new techniques of MR, the qualification of accuracy and negative predicating value of MR in differential diagnosis is elevated. At the same time, as the number of patients with early prostate carcinoma or non-tumoral lesion in prostate gland increasing, the qualification of positive predicating value drops slightly.